Internal Medicine, Endocrinology, Diabetes, & Metabolism · Las Vegas, NV
NPI
1902097215
Since 2007
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
2880 N Tenaya Way Ste 320
Las Vegas, NV, 89128
Phone (702) 862-8226
Groups this clinician bills Medicare through
Medicare paid, 2024
$44K
1,663 services
Medicare patients, 2024
147
Average age 73
Drug cost, 2024
$1.8M
4,096 prescriptions
Company payments, 2025
$135
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Chard D Bubb was code J0897 (injection, denosumab, 1 mg), 1,320 times for 18 patients. In total Chard D Bubb billed 1,663 services in 21 codes, and Medicare paid $44K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-10-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 1,320 | 18 | $20.32 | $27K |
| 99214 Office E&M - Established | Office | 148 | 95 | $86.57 | $13K |
| 96372 Injection Administration | Office | 36 | 22 | $9.60 | $346 |
| 95251 Test - Miscellaneous | Office | 20 | 15 | $25.29 | $506 |
| 99213 Office E&M - Established | Office | 20 | 18 | $56.56 | $1,131 |
By year: 2022 $46K for 1,994 services; 2023 $54K for 2,313 services; 2024 $44K for 1,663 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 17 | 17 | $3.21 | $54.57 |
Medicare prescription drug claims, 2024
In 2024, the drug Chard D Bubb prescribed most often to Medicare patients was Levothyroxine Sodium, with 301 prescriptions and refills. In total Chard D Bubb wrote 4,096 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 301 | 887 | 104 | $2,658 |
| Mounjaro Tirzepatide | 214 | 306 | 49 | $324K |
| Jardiance Empagliflozin | 209 | 432 | 65 | $254K |
| Trulicity Dulaglutide | 167 | 238 | 46 | $232K |
| Metformin Hcl Er Metformin Hcl | 165 | 467 | 61 | $902 |
| Ozempic Semaglutide | 162 | 287 | 53 | $245K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 155 | 383 | 59 | $28K |
| Atorvastatin Calcium Generic | 143 | 411 | 58 | $1,184 |
| Metformin Hcl Generic | 140 | 397 | 51 | $973 |
| Glipizide Er Glipizide | 137 | 381 | 46 | $1,539 |
| Methimazole Generic | 131 | 333 | 40 | $898 |
| Tresiba Flextouch U-100 Insulin Degludec | 104 | 236 | 35 | $80K |
| Glipizide Generic | 97 | 271 | 33 | $475 |
| Novolog Flexpen Insulin Aspart | 92 | 218 | 42 | $31K |
| Alendronate Sodium Generic | 70 | 173 | 22 | $389 |
Brand drugs: 2,037 claims; generic drugs: 1,766 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Chard D Bubb $135 ($135 in general payments such as food, travel and fees) from 2 companies. The largest payer was Recordati_rare_diseases_inc. with $121.
| Company | Payments | Amount |
|---|---|---|
| Recordati_rare_diseases_inc. | 1 | $121 |
| Insulet Corporation PODD | 1 | $14.01 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.